EUDA Health (EUDA)
Market Price (11/18/2025): $2.8 | Market Cap: $61.8 MilSector: Real Estate | Industry: Real Estate Services
EUDA Health (EUDA)
Market Price (11/18/2025): $2.8Market Cap: $61.8 MilSector: Real EstateIndustry: Real Estate Services
Investment Highlights
Why It Matters
Which of these 2 stories sounds closer for this stock?
1. Generates cash flow
The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.
2. Riding a trend
Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow
| Megatrend and thematic driversMegatrends include Digital Health & Telemedicine. Themes include Telehealth Platforms, Health Data Analytics, and AI in Healthcare Management. | Weak multi-year price returns3Y Excs Rtn is -118% | Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -4.4 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -63% |
| Not cash flow generativeCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -49%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -49% | ||
| Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -21% | ||
| High stock price volatilityVol 12M is 105% |
| Megatrend and thematic driversMegatrends include Digital Health & Telemedicine. Themes include Telehealth Platforms, Health Data Analytics, and AI in Healthcare Management. |
| Weak multi-year price returns3Y Excs Rtn is -118% |
| Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -4.4 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -63% |
| Not cash flow generativeCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -49%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -49% |
| Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -21% |
| High stock price volatilityVol 12M is 105% |
Market Valuation & Key Metrics
EUDA Stock
Why The Stock Moved
Qualitative Assessment
AI Generated Analysis | Feedback
Here are the key points for the approximate -10.1% stock movement of EUDA Health (symbol: EUDA) from July 31, 2025, to November 18, 2025:
1. Auditor's "Going Concern" Doubt: An amended annual report for fiscal year 2024, filed on September 23, 2025, revealed that EUDA Health's auditor expressed "substantial doubt" about the company's ability to continue as a going concern. This concern stemmed from significant accumulated deficits totaling over $50 million and ongoing losses, indicating a precarious financial state where liabilities exceeded assets.
2. Negative Earnings Growth Forecasts: Analysts projected a substantial negative annual earnings growth rate of -77.33% for EUDA Health for the 2025-2026 period. This forecast significantly lagged behind the average expected growth rates for both the US Health Information Services industry and the broader US market.
Stock Movement Drivers
Return vs. Risk
Price Returns Compared
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| EUDA Return | - | - | -83% | -13% | 213% | -38% | -72% |
| Peers Return | 9% | -8% | -35% | 60% | -12% | 73% | 58% |
| S&P 500 Return | 16% | 27% | -19% | 24% | 23% | 13% | 107% |
Monthly Win Rates [3] | |||||||
| EUDA Win Rate | - | 67% | 42% | 83% | 30% | ||
| Peers Win Rate | 33% | 25% | 20% | 32% | 22% | 52% | |
| S&P 500 Win Rate | 58% | 75% | 42% | 67% | 75% | 70% | |
Max Drawdowns [4] | |||||||
| EUDA Max Drawdown | - | - | -86% | -70% | -15% | -77% | |
| Peers Max Drawdown | -15% | -17% | -36% | -5% | -18% | -22% | |
| S&P 500 Max Drawdown | -31% | -1% | -25% | -1% | -2% | -15% | |
[1] Cumulative total returns since the beginning of 2020
[2] Peers: OPEN, GBR, GYRO, HBNB, LHAI.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 11/17/2025 (YTD)
How Low Can It Go
| Event | EUDA | S&P 500 |
|---|---|---|
| 2022 Inflation Shock | ||
| % Loss | -95.0% | -25.4% |
| % Gain to Breakeven | 1910.4% | 34.1% |
| Time to Breakeven | Not Fully Recovered days | 464 days |
Compare to OPEN, GBR, GYRO, HBNB, LHAI
In The Past
EUDA Health's stock fell -95.0% during the 2022 Inflation Shock from a high on 10/31/2022. A -95.0% loss requires a 1910.4% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth over time.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
Latest Trefis Analyses
| Title | |
|---|---|
| ARTICLES |
Trade Ideas
Select past ideas related to EUDA. For more, see Trefis Trade Ideas.
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 10312025 | MPW | Medical Properties Trust | Special | Short Squeeze PotentialShort Squeeze PotentialHas potential for a short squeeze. High short interest, rising short interest and high debt. | -4.3% | -4.3% | -5.8% |
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 10312025 | MPW | Medical Properties Trust | Special | Short Squeeze PotentialShort Squeeze PotentialHas potential for a short squeeze. High short interest, rising short interest and high debt. | -4.3% | -4.3% | -5.8% |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons for EUDA Health
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 6.96 |
| Mkt Cap | 0.0 |
| Rev LTM | 7 |
| Op Inc LTM | -3 |
| FCF LTM | -0 |
| FCF 3Y Avg | 49 |
| CFO LTM | -0 |
| CFO 3Y Avg | 49 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 1.5% |
| Rev Chg 3Y Avg | 2.1% |
| Rev Chg Q | 3.1% |
| QoQ Delta Rev Chg LTM | 0.9% |
| Op Mgn LTM | -50.0% |
| Op Mgn 3Y Avg | -141.8% |
| QoQ Delta Op Mgn LTM | -0.9% |
| CFO/Rev LTM | -26.5% |
| CFO/Rev 3Y Avg | 15.2% |
| FCF/Rev LTM | -26.5% |
| FCF/Rev 3Y Avg | 14.8% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 0.0 |
| P/S | 5.0 |
| P/EBIT | -11.8 |
| P/E | -12.2 |
| P/CFO | -9.3 |
| Total Yield | -3.5% |
| Dividend Yield | 0.0% |
| FCF Yield 3Y Avg | 60.3% |
| D/E | 0.2 |
| Net D/E | 0.1 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | -4.9% |
| 3M Rtn | 25.9% |
| 6M Rtn | -4.1% |
| 12M Rtn | -17.6% |
| 3Y Rtn | -15.0% |
| 1M Excs Rtn | -5.0% |
| 3M Excs Rtn | 41.7% |
| 6M Excs Rtn | -16.0% |
| 12M Excs Rtn | -30.6% |
| 3Y Excs Rtn | -86.4% |
Returns Analyses
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 6302025 | 10012025 | 6-K 6/30/2025 |
| 12312024 | 4292025 | 20-F 12/31/2024 |
| 6302024 | 10182024 | 6-K 6/30/2024 |
| 12312023 | 5092024 | 20-F 12/31/2023 |
| 6302023 | 12292023 | 6-K 6/30/2023 |
| 3312023 | 7312023 | 10-Q 3/31/2023 |
| 12312022 | 6282023 | 10-K 12/31/2022 |
| 12312021 | 9082022 | PRER14A 12/31/2021 |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |